MarketPulse
P

$PRCT

4 articles found
0 positive
4 negative
0 neutral
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

PRCT Stock Plunges 15% After Revenue Miss Triggers Securities Fraud Investigation

PROCEPT BioRobotics faces securities fraud investigation after missing earnings and cutting 2026 guidance by $20-30 million, triggering a 15% stock plunge.
PRCTshareholder lawsuitstock price decline
BenzingaBenzinga··Business Wire

PROCEPT BioRobotics Faces Securities Fraud Investigation After Earnings Miss, Stock Plunges 15%

Law firm launches investigation into $PRCT over alleged securities violations following disappointing earnings report and major revenue guidance cut.
PRCTstock declineshareholder lawsuit
BenzingaBenzinga··Business Wire

PROCEPT Faces Securities Investigation After Disappointing Q4 Results

PROCEPT BioRobotics faces securities fraud investigation after Q4 earnings missed expectations, guidance slashed, stock down 15.1%.
PRCTstock declinerevenue miss
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

PRCT Stock Plunges 15% as PROCEPT Slashes Guidance Amid Commercial Turmoil

PROCEPT BioRobotics faces securities fraud investigation after missing Q4 2025 revenue and slashing 2026 guidance by $20-40 million, prompting 15% stock decline.
PRCTsecurities fraudclass action lawsuit